Patents by Inventor Joel Nelson
Joel Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240125152Abstract: An anti-theft device for securing an article of merchandise against unauthorized removal from a display counter. The anti-theft device comprises a latch plate and a pedestal having a quick-release interface. The latch plate is configured to selectively couple to the quick-release interface. A latch bolt is disposed within the pedestal. The latch bolt locks the latch plate relative to the quick-release interface. A plurality of retaining arms is configured to receive and retain an article of merchandise. The retaining arms cannot be disengaged from the article of merchandise while the latch plate is locked relative to the quick-release interface. A solenoid is housed within the pedestal and operationally connected to the latch bolt. The solenoid is configured to retract the latch bolt into a position in which the latch bolt disengages the latch plate, thereby releasing the latch plate from the quick-release interface.Type: ApplicationFiled: December 12, 2023Publication date: April 18, 2024Applicant: Vanguard Products Group, Inc.Inventors: Christopher A. Kelsch, Douglas Barthold, Joel Jenkins, Sarah Johnson, Chris Nelson, Wade Zhu, Matthew Kuntz, Lee Eckert, John N. Figh, JR., Jasen Paul Biggins
-
Patent number: 11961149Abstract: A method for monitoring disease across agricultural areas of interest is provided comprising displaying at least one virtual zone corresponding to an agricultural geographic area of interest on a map in an application on a first device, and receiving an alert message when the first device is in proximity to a virtual zone. The at least one virtual zone is defined by at least one geofence. Each virtual zone is associated with a level of risk that indicates a likelihood of an outbreak of a disease detrimental to agriculture. Each virtual zone is configured to receive access notification information from each geofence when tracked devices enter an area defined by that geofence. The access information includes the level of risk associated with other virtual zones from which the tracked devices came. The alert message indicates if the first device should enter that virtual zone.Type: GrantFiled: January 9, 2023Date of Patent: April 16, 2024Assignee: FARM HEALTH GUARDIAN LTD.Inventors: Timothy Nelson, Joel Roberto Sotomayor
-
Patent number: 11008624Abstract: The present invention relates to methods for determining whether a subject having prostate cancer is at an increased risk for relapse or rapid relapse. It is based, at least in part, on the results of a comprehensive genome analysis of 273 prostate cancer samples, which indicate that the percentage of large size CNVs predicts prostate cancer relapse. In certain embodiments, a method for determining whether a prostate cancer patient has an increased risk of suffering a relapse or a rapid relapse comprises determining the number and size of CNVs in a sample and determining a large size ratio, where if the large size ratio exceeds a particular threshold, the patient is deemed to be at an increased risk for relapse or rapid relapse.Type: GrantFiled: February 7, 2018Date of Patent: May 18, 2021Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONInventors: Jianhua Luo, Yanping Yu, Chien-Cheng Tseng, Shuchang Liu, George Michalopoulos, Joel Nelson
-
Patent number: 10822622Abstract: The present invention relates to methods for treating prostate cancer patients. It is based, at least in part, on the discovery that approximately 90% of men carrying at least one of the following fusion genes: TRMT11-GRIK2, SLC45A2-AMACR, MTOR-TP53BP1, LRRC59-FLJ60017, TMEM135-CCDC67 and CCNH-C5orf30 experienced prostate cancer recurrence, metastases and/or prostate cancer-specific death after radical prostatectomy (each examples of “progressive prostate cancer”), while these outcomes occurred in only 36% of men not carrying any of these fusion genes. It is also based, at least in part, on the discovery that a genome editing technique that specifically targets a fusion gene can induce cell death in a cancer cell that carries the fusion gene.Type: GrantFiled: March 18, 2019Date of Patent: November 3, 2020Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONInventors: Jianhua Luo, Yanping Yu, Zhanghui Chen, George Konstantine Michalopoulos, Joel Nelson
-
Publication number: 20190203231Abstract: The present invention relates to methods for treating prostate cancer patients. It is based, at least in part, on the discovery that approximately 90% of men carrying at least one of the following fusion genes: TRMT11-GRIK2, SLC45A2-AMACR, MTOR-TP53BP1, LRRC59-FLJ60017, TMEM135-CCDC67 and CCNH-C5orf30 experienced prostate cancer recurrence, metastases and/or prostate cancer-specific death after radical prostatectomy (each examples of “progressive prostate cancer”), while these outcomes occurred in only 36% of men not carrying any of these fusion genes. It is also based, at least in part, on the discovery that a genome editing technique that specifically targets a fusion gene can induce cell death in a cancer cell that carries the fusion gene.Type: ApplicationFiled: March 18, 2019Publication date: July 4, 2019Applicant: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONInventors: Jianhua Luo, Yanping Yu, Zhanghui Chen, George Konstantine Michalopoulos, Joel Nelson
-
Patent number: 10308960Abstract: The present invention relates to methods for treating prostate cancer patients. It is based, at least in part, on the discovery that approximately 90% of men carrying at least one of the following fusion genes: TRMT11-GRIK2, SLC45A2-AMACR, MTOR-TP53BP1, LRRC59-FLJ60017, TMEM135-CCDC67 and CCNH-05orf30 experienced prostate cancer recurrence, metastases and/or prostate cancer-specific death after radical prostatectomy (each examples of “progressive prostate cancer”), while these outcomes occurred in only 36% of men not carrying any of these fusion genes. It is also based, at least in part, on the discovery that a genome editing technique that specifically targets a fusion gene can induce cell death in a cancer cell that carries the fusion gene.Type: GrantFiled: January 13, 2017Date of Patent: June 4, 2019Assignee: University of Pittsburgh - of the Commonwealth System of Higher EducationInventors: Jianhua Luo, Yanping Yu, Zhanghui Chen, George Konstantine Michalopoulos, Joel Nelson
-
Patent number: 10228399Abstract: A smart sensor system can include one or more configurable input and output channels, each configurable channel including one or more switches configured to activate the input and/or output and/or to select a type of input and/or output signal, at least one analog-to-digital converter and at least one digital-to-analog converter operatively connected to the one or more switches for the one or more configurable channels, and at least one controller configured to control the configurable channels.Type: GrantFiled: January 12, 2017Date of Patent: March 12, 2019Assignee: Simmonds Precision Products, Inc.Inventors: Benjamin D. McBride, Peter J. Carini, Matthew B. Burleigh, Travis Gang, Joel Nelson
-
Publication number: 20180230547Abstract: The present invention relates to methods for determining whether a subject having prostate cancer is at an increased risk for relapse or rapid relapse. It is based, at least in part, on the results of a comprehensive genome analysis of 273 prostate cancer samples, which indicate that the percentage of large size CNVs predicts prostate cancer relapse. In certain embodiments, a method for determining whether a prostate cancer patient has an increased risk of suffering a relapse or a rapid relapse comprises determining the number and size of CNVs in a sample and determining a large size ratio, where if the large size ratio exceeds a particular threshold, the patient is deemed to be at an increased risk for relapse or rapid relapse.Type: ApplicationFiled: February 7, 2018Publication date: August 16, 2018Applicant: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONInventors: Jianhua Luo, Yanping Yu, Chien-Cheng Tseng, Shuchang Liu, George Michalopoulos, Joel Nelson
-
Publication number: 20180196089Abstract: A smart sensor system can include one or more configurable input and output channels, each configurable channel including one or more switches configured to activate the input and/or output and/or to select a type of input and/or output signal, at least one analog-to-digital converter and at least one digital-to-analog converter operatively connected to the one or more switches for the one or more configurable channels, and at least one controller configured to control the configurable channels.Type: ApplicationFiled: January 12, 2017Publication date: July 12, 2018Inventors: Benjamin D. McBride, Peter J. Carini, Matthew B. Burleigh, Travis Gang, Joel Nelson
-
Publication number: 20170240924Abstract: The present invention relates to methods for treating prostate cancer patients. It is based, at least in part, on the discovery that approximately 90% of men carrying at least one of the following fusion genes: TRMT11-GRIK2, SLC45A2-AMACR, MTOR-TP53BP1, LRRC59-FLJ60017, TMEM135-CCDC67 and CCNH-C5orf30 experienced prostate cancer recurrence, metastases and/or prostate cancer-specific death after radical prostatectomy (each examples of “progressive prostate cancer”), while these outcomes occurred in only 36% of men not carrying any of these fusion genes. It is also based, at least in part, on the discovery that a genome editing technique that specifically targets a fusion gene can induce cell death in a cancer cell that carries the fusion gene.Type: ApplicationFiled: January 13, 2017Publication date: August 24, 2017Inventors: JIANHUA LUO, Yanping Yu, Zhanghui Chen, George Konstantine Michalopoulos, Joel Nelson
-
Publication number: 20140235378Abstract: Support structures and bats such as those that may be used in the game of baseball are disclosed herein. Certain embodiments include a plurality of appendages within a bat barrel that both arc toward the bat barrel and form an arc adjacent to the inside of the bat barrel. Sport structures having a central hub within the barrel of a bat are also disclosed.Type: ApplicationFiled: February 21, 2013Publication date: August 21, 2014Inventor: Joel Nelson Albin
-
Publication number: 20110112447Abstract: A portable active pneumatically-powered ankle foot orthosis. A lower leg mount and a foot bed are pivotally coupled at or proximate to an ankle position. A pneumatically powered rotary actuator is configured to receive power from a wearable fluid power source and provide controlled force and resistance to aid or inhibit relative rotation of the foot bed and the lower leg mount. Embedded sensors provide feedback from the device.Type: ApplicationFiled: October 5, 2010Publication date: May 12, 2011Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Elizabeth T. Hsiao-Wecksler, Joel Nelson Gilmer, Geza Kogler, Eric Loth, K. Alex Shorter, Jason Evan Thomas
-
Publication number: 20070110500Abstract: A dispenser for cosmetic materials includes a hollow body containing a flowable cosmetic material, a cap having a wand member with a cosmetic applicator tip that extends through a sleeve that limits the distance that the tip protrudes into the body, or through a screen/wiper tube inside the body, the tube including a distal opening that engages the tip as it passes through the opening and into contact with the cosmetic material when the cap is in contact with the body, and regulates the amount of cosmetic material carried by the tip as it is withdrawn from the cosmetic material.Type: ApplicationFiled: October 25, 2006Publication date: May 17, 2007Inventors: Monroe Cochran, Laura Nelson, Joel Nelson, Jeffrey Hager